Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$7.85
-7.81%
Mkt Cap $534.88M
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+88.0%
Consensus $14.75 vs current $7.85
NASDAQ·Healthcare·Biotechnology
$7.85
-7.81%
Mkt Cap $534.88M
Buy
7
Hold
2
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+88.0%
Consensus $14.75 vs current $7.85